Page 5 - Vaccine

Vaccines must be central strategy to fight Covid-19 pandemic: WHO official

The best chance to end the public health emergency depends on the vitality of vaccine equity, a WHO official said

Omicron spread: Booster dose takes off, day 1 nears 1-million mark

Over 930,000 people receive precautionary third shot of Covid-19 vaccine

Risk-taker gets a booster dose: Meet Adar Poonawalla, CEO, Serum Institute

SII invests 90-95 per cent of its profits every year to build capacities

Cumulative Covid vaccine doses administered in India reach 142.38 cr: Govt

More than 6,520,037 vaccine doses were administered till 7 pm Monday

Children above 15 to get Bharat Biotech's Covaxin only, for now

The Centre is of the opinion that booster shots are population- and frequency-specific interventions

A booster for India

Govt decision on vaccination is in the right direction

Covishield third jab works against Omicron variant, says Oxford

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India

Covid-19 pandemic: Covovax data with DCGI, approval expected soon

India has said any vaccine that has approval from stringent regulatory bodies like the USFDA, UK-MHRA, etc., will be approved for use in India

Pfizer study tests extra Covid-19 vaccine dose for kids under 5

For children younger than 5, Pfizer is testing an even smaller dose, just 3 micrograms or a tenth of the adult dose

CDC panel recommends Pfizer, Moderna Covid vaccines over J&J shot

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations while the Pfizer and Moderna vaccines don't come with that risk and also appear to be more effective, advisers to the Centers for Disease Control and Prevention said. It's an unusual move and the CDC's director, Dr. Rochelle Walensky, must decide whether to accept the panel's advice. Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option that could be especially important for hard-to-reach groups like homeless people who might not get the needed second dose of the Pfizer or Moderna options. But the CDC's ..

Booster shots for 40+ and frontline workers to cost govt another Rs 10k cr

If booster shots are given on priority, the pace of vaccination may slow further. In the worst case scenario, the country will take till mid-March to vaccinate its entire adult population partially.

Our vaccines may become ineffective in emerging situations, says V K Paul

"We need 7.2 billion doses together, and with the current rate of production, it is well within our grasp... it is possible for us to deliver the vaccine," Paul said

India to produce 5 billion Covid vaccine doses next year: Piyush Goyal

Goyal said India was ready to export as many doses as partner nations require

Vaccine booster shots: Experts studying benefits before India forges ahead

Some experts also argue that companies sitting on big vaccine stocks are using boosters as a marketing strategy to sell more vaccines

CMC Vellore calls for volunteers for Covaxin vaccine booster dose trials

The findings for recipients of Covishield will be released along with those with Covaxin trial data once the study for both vaccines is over

Over 132 crore Covid vaccine doses administered in India so far: Govt

The countrywide vaccination drive was rolled out on January 16

Will vaccine crunch hurt India's ongoing fight against Covid-19?

Serum Institute is going to cut down production of Covishield as there's no order from the govt. But some states don't have enough vaccine in store. Find out if India is well-stocked to fight Covid-19

Vladimir Putin hopes WHO soon approves Russia's Sputnik V vaccine

Russia was the first country in the world to authorise a coronavirus vaccine, launching Sputnik V in August 2020, and has plentiful supplies

Vaccine hoarding by some countries leading to new Covid-19 variants?

Just as we thought that we were out of the woods, the threat of a new Covid-19 variant, Omicron, has started looming large. Let's take a look at the factors that have contributed to the crisis

Russia starts developing new Covid-19 vaccine against Omicron variant

If modification is needed, the new Sputnik Omicron version can be ready for mass production in 45 days